Prostaglandin E2 signaling via its receptor EP4 on macrophages protects against acute colitis by preserving intestinal barrier function

被引:0
作者
Murray, Page [1 ]
Kelsall, Brian [1 ]
机构
[1] NIAID, NIH, Bethesda, MD USA
关键词
D O I
10.4049/jimmunol.210.Supp.61.15
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Prostaglandin E2 Receptor EP4 Inhibition Contracts Rat Ductus Arteriosus
    Sakuma, Toshiki
    Akaike, Toru
    Minamisawa, Susumu
    CIRCULATION JOURNAL, 2019, 83 (01) : 209 - 216
  • [42] The prostaglandin E2 EP4 receptor is pro-tumorigenic in mouse skin
    Simper, Melissa
    Bowen, Rebecca
    Surh, Inok
    Fischer, Susan
    CANCER RESEARCH, 2009, 69
  • [43] Diverse Actions of the EP4 Prostaglandin E2 Receptor in Blood Pressure Control
    Herrera, Marcela
    Sparks, Matthew A.
    Koller, Beverky H.
    Coffman, Thomas M.
    HYPERTENSION, 2013, 62 (03)
  • [44] Role of the prostaglandin E2 receptor subtype EP4 in ischemic brain injury
    Kojima, Fumiaki
    Ri, Akimasa
    Yuhki, Koh-ichi
    Suzuki, Yasuhiro
    Kashiwagi, Hitoshi
    Narumiya, Shuh
    Ushikubi, Fumitaka
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 79P - 79P
  • [45] Overexpression of prostaglandin E2 EP4 receptor enhances mouse skin tumorigenesis
    Simper, Melissa S.
    Bowen, Rebecca A.
    Surh, Inok
    Fischer, Susan M.
    CANCER RESEARCH, 2010, 70
  • [46] The tumor promoting activity of the EP4 receptor for prostaglandin E2 in murine skin
    Simper, Melissa S.
    Rundhaug, Joyce E.
    Mikulec, Carol
    Bowen, Rebecca
    Shen, Jianjun
    Lu, Yue
    Lin, Kevin
    Surh, Inok
    Fischer, Susan M.
    MOLECULAR ONCOLOGY, 2014, 8 (08) : 1626 - 1639
  • [47] Role of EP2 and EP4 receptor-selective agonists of prostaglandin E2 in acute and chronic kidney failure
    Vukicevic, S.
    Simic, P.
    Borovecki, F.
    Grgurevic, L.
    Rogic, D.
    Orlic, I.
    Grasser, W. A.
    Thompson, D. D.
    Paralkar, V. M.
    KIDNEY INTERNATIONAL, 2006, 70 (06) : 1099 - 1106
  • [48] Paricalcitol Attenuates Renal Ischemia-Reperfusion Injury Via Prostaglandin E2 Receptor EP4
    Hwang, H.
    Yang, K.
    Park, K.
    Choi, H.
    Oh, J.
    Chang, Y.
    Park, C.
    Kim, S.
    Yang, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 345 - 346
  • [49] Paricalcitol Attenuates Renal Ischemia-Reperfusion Injury Via Prostaglandin E2 Receptor EP4
    Hwang, H.
    Yang, K.
    Park, K.
    Choi, H.
    Oh, J.
    Chang, Y.
    Park, C.
    Kim, S.
    Yang, C.
    TRANSPLANTATION, 2014, 98 : 345 - 346
  • [50] Troglitazone suppresses the expression of prostaglandin E2 receptor subtype EP4 via MEK/Erk pathway
    Kambe, A
    Moon, Y
    Iguchi, G
    Kamitani, H
    Watanabe, T
    Eling, TE
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2006, 79 (1-2) : 191 - 191